Literature DB >> 30215894

Chronic Nonallergic Rhinitis.

Denise K C Sur1, Monica L Plesa1.   

Abstract

Chronic nonallergic rhinitis encompasses a group of rhinitis subtypes without allergic or infectious etiologies. Although chronic nonallergic rhinitis represents about one-fourth of rhinitis cases and impacts 20 to 30 million patients in the United States, its pathophysiology is unclear and diagnostic testing is not available. Characteristics such as no evidence of allergy or defined triggers help define clinical subtypes. There are eight subtypes with overlapping presentations, including nonallergic rhinopathy, nonallergic rhinitis with nasal eosinophilia syndrome, atrophic rhinitis, senile or geriatric rhinitis, gustatory rhinitis, drug-induced rhinitis, hormonal rhinitis, and occupational rhinitis. Treatment is symptom-driven and similar to that of allergic rhinitis. Patients should avoid known triggers when possible. First-line therapies include intranasal corticosteroids, intranasal antihistamines, and intranasal ipratropium. Combination therapy with decongestants and first-generation antihistamines can be considered if monotherapy does not adequately control symptoms. Nasal irrigation and intranasal capsaicin may be helpful but need further investigation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30215894

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  2 in total

1.  The Beneficial Effects of Hydrogen-Rich Saline Irrigation on Chronic Rhinitis: A Randomized, Double-Blind Clinical Trial.

Authors:  Ling Jin; Kai Fan; Shiwang Tan; Shangxi Liu; Qin Ge; Yang Wang; Zisheng Ai; Shaoqing Yu
Journal:  J Inflamm Res       Date:  2022-07-15

2.  Pharmacist's recommendations of over-the-counter treatments for the common cold - analysis of prospective cases in Poland.

Authors:  Malgorzata Pietrusiewicz; Paulina Natalia Kopa-Stojak; Rafal Pawliczak
Journal:  BMC Fam Pract       Date:  2021-10-30       Impact factor: 2.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.